Free Trial
→ From the man who predicted 2008 crash… (From Porter & Company) (Ad)tc pixel Free AGY Stock Alerts

Allergy Therapeutics (AGY) Stock Chart & Stock Price History

Allergy Therapeutics logo
GBX 9.98 0.00 (0.00%)
As of 05:13 AM Eastern
Compare

Allergy Therapeutics Stock Price Performance

The Allergy Therapeutics (AGY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 42.57%, with a year-to-date return of -10.89%. In the past month, the stock has decreased 6.73%, reflecting recent market activity.

As of the latest close, Allergy Therapeutics traded at GBX 9.98 with a market cap of £631.99 million and volume of 254,270 shares. Five years ago, the stock traded at GBX 23.25, representing a 57.08% decrease over that period. At the time, it had a market cap of £148.98 million and a volume of 411,461 shares.

Receive AGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-8.02%
1 Month
Performance
-6.73%
3 Month
Performance
-7.59%
Year-To-Date
Performance
-10.89%
1 Year
Performance
+42.57%
5 Year
Performance
-57.08%

AGY Stock Chart for Thursday, May, 14, 2026

AGY Chart by TradingView

Allergy Therapeutics Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 9.90GBX 9.98
+0.81%		GBX 10.50GBX 9254,270 shs£631.99 million
05/12/2026GBX 10GBX 9.90
-1.00%		GBX 10.50GBX 9184,771 shs£626.92 million
05/11/2026GBX 10.85GBX 10
-7.83%		GBX 10.50GBX 9.50255,043 shs£633.25 million
05/08/2026GBX 10.25GBX 10.85
+5.85%		GBX 10.85GBX 9.60118,636 shs£687.08 million
05/07/2026GBX 10.20GBX 10.25
+0.49%		GBX 11GBX 9.76308,635 shs£649.08 million
05/06/2026GBX 10.50GBX 10.20
-2.86%		GBX 11GBX 9330,232 shs£645.92 million
05/05/2026N/AGBX 10.50GBX 11GBX 9.5090,479 shs£664.92 million
04/30/2026GBX 10GBX 10.95
+9.50%		GBX 10.95GBX 9.50368,569 shs£693.41 million
04/29/2026GBX 10.30GBX 10
-2.91%		GBX 10.90GBX 9.88322,724 shs£633.25 million
04/28/2026GBX 10.90GBX 10.30
-5.50%		GBX 10.60GBX 9173,636 shs£652.25 million
04/27/2026GBX 10.50GBX 10.90
+3.81%		GBX 10.90GBX 9186,741 shs£690.25 million
04/24/2026GBX 10.90GBX 10.50
-3.67%		GBX 10.90GBX 10.01180,855 shs£664.92 million
04/23/2026GBX 10.90GBX 10.90GBX 10.90GBX 10.1617,336 shs£690.25 million
04/22/2026GBX 10.90GBX 10.90GBX 10.90GBX 10140,300 shs£690.25 million
04/21/2026GBX 10.90GBX 10.90GBX 10.90GBX 10.16104,980 shs£690.25 million
04/20/2026GBX 10.59GBX 10.90
+2.95%		GBX 11GBX 10.1688,876 shs£690.25 million
04/17/2026GBX 10.40GBX 10.59
+1.81%		GBX 10.60GBX 10.11390,663 shs£670.49 million
04/16/2026GBX 10.90GBX 10.40
-4.59%		GBX 10.90GBX 10.13658,160 shs£658.58 million
04/15/2026GBX 10.70GBX 10.90
+1.87%		GBX 11GBX 10.36182,344 shs£690.25 million
04/14/2026GBX 10.80GBX 10.70
-0.93%		GBX 11GBX 10.7025,618 shs£677.58 million
04/13/2026GBX 10.80GBX 10.80GBX 10.90GBX 1095,286 shs£683.91 million
Related Companies

This page (LON:AGY) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Is this AI lab Elon’s SpaceX lifeline?
Elon Musk went from calling one AI lab 'evil' to striking a deal giving it access to SpaceX's entire Colossus ...
Chaikin Analytics | Sponsoredtc pixel
The one number Musk can't hide in the S-1
When SpaceX files its S-1 in June, one number will stand out - power consumption. Running 1 million GPUs requi...
Behind the Markets | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
The system holding the dollar together is gone…
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
SpaceX IPO Warning: Before you buy any SpaceX shares, read this.
The SpaceX IPO is valued at $1.75 trillion - but buying shares directly may not be the strongest play availabl...
Weiss Ratings | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel
SpaceX just filed. The clock is ticking.
Reuters reports Elon Musk filed secretly. Barron's says it's being finalized behind closed doors. CNBC just re...
The Oxford Club | Sponsoredtc pixel
Millionaire trader: “Buy this before May 15.”
Hedge fund legend Larry Benedict - who beat the S&P 500 by 18 times in 2025 and generated $95 million for clie...
Brownstone Research | Sponsoredtc pixel